immune reset

Search documents
Artiva Biotherapeutics (ARTV) 2025 Conference Transcript
2025-09-03 14:47
Artiva Biotherapeutics (ARTV) 2025 Conference September 03, 2025 09:45 AM ET Company ParticipantsJosh Schimmer - Managing DirectorFred Aslan - President, CEO & DirectorJosh SchimmerAll right, I think we're ready to get started. Welcome everyone. I'm Josh Shimmer from the Kanter Biotech Equity Research Team. Very pleased to introduce from Artiva Biotherapeutics, Fred Aslan, Chief Executive Officer, to give us a snapshot of the program. I have a feeling we're going to be talking a lot about CYFLU during the c ...